Meet the Dividend King That's Quietly Crushing the S&P 500 in 2026. Here's Why It's a Buy in November.

Target shares are up 51% year to date as the article credits an improving business and CEO Michael Fiddelke’s turnaround efforts, following several years of declining revenue and market-share losses. The company raised its annual sales-growth outlook from 2% to 5% and expects annual EPS of $9.90–$10.90; the stock trades at about 14 times the midpoint of that range. Target has raised its dividend for 55 consecutive years and yields 3.1%, with fiscal Q3 results due Nov. 18.

Analysis

The key question is whether improved sales are converting into durable, higher-quality earnings—not whether the turnaround narrative is gaining traction. A sales beat accompanied by heavier promotions, weaker gross margin, or rising inventory would expose a low-quality recovery: Target could keep raising revenue expectations while the earnings multiple and dividend-growth case lose support. Conversely, stable margins alongside continued comp growth would make the current earnings-based valuation more credible. Verify comparable-sales drivers, gross margin, inventory, and free cash flow; the article does not establish how much of the guidance increase is structural.

The 51% year-to-date advance raises the bar for the Nov. 18 report: good results may be insufficient if they merely confirm elevated expectations. Near term, earnings and guidance are the catalyst; over 1–3 months, evidence that customers are returning without greater promotional intensity matters more than another sales-guidance increase. Over 6–18 months, execution on assortment and store investment could improve competitiveness, but also consumes resources before payback is proven. Walmart and Amazon can pressure price and convenience; TJX competes for discretionary spending. A long dividend record is not a substitute for cash-flow coverage.

Contrarian view: the headline valuation may look undemanding only if guidance EPS is sustainable. After the rally, the risk is not simply a weak quarter; it is a reset in the earnings denominator if margins fail to recover. No clear basis here to chase ahead of the event.

Key Decisions for Investors

• Avoid adding aggressively before Nov. 18. Treat the report as a high-information catalyst and watch whether comparable-sales strength is accompanied by stable or improving gross margin and inventory discipline.
• For investors seeking exposure, consider a small, staged TGT long after the report only if management sustains its outlook and results show sales translating into earnings and free cash flow; do not rely on the dividend streak as downside protection.
• Falsify the recovery thesis if Target cuts its outlook, comparable-sales growth depends on heavier discounting, or inventory rises faster than sales. Reassess promptly if any of those appear in the Q3 release or outlook.
• If the quarter shows revenue momentum but deteriorating margins, reduce exposure rather than treating a sales beat as confirmation; that combination would suggest the market is overestimating the durability of the earnings recovery.